Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia risk

Eur Heart J. 2015 Jan 14;36(3):179-86. doi: 10.1093/eurheartj/ehu370. Epub 2014 Sep 8.

Abstract

Aim: Prolonged and dispersed left-ventricular (LV) contraction is present in patients with long-QT syndrome (LQTS). Electrical and mechanical abnormalities appear most pronounced in symptomatic individuals. We focus on the 'electromechanical window' (EMW; duration of LV-mechanical systole minus QT interval) in patients with genotyped LQTS. Profound EMW negativity heralds torsades de pointes in animal models of drug-induced LQTS.

Methods and results: We included 244 LQTS patients from three centres, of whom 97 had experienced arrhythmic events. Seventy-six matched healthy individuals served as controls. QT interval was subtracted from the duration of Q-onset to aortic-valve closure (QAoC) midline assessed non-invasively by continuous-wave echocardiography, measured in the same beat. Electromechanical window was positive in controls but negative in LQTS patients (22 ± 19 vs. -43 ± 46 ms; P < 0.0001), being even more negative in symptomatic than event-free patients (-67 ± 42 vs. -27 ± 41 ms; P < 0.0001). QT, QTc, and QAoC were longer in LQTS subjects (451 ± 57, 465 ± 50, and 408 ± 37 ms, P < 0.0001). Electromechanical window was a better discriminator of patients with previous arrhythmic events than resting QTc (AUC 0.77 (95% CI, 0.71-0.83) and 0.71 (95% CI, 0.65-0.78); P = 0.03). In multivariate analysis, EMW predicted arrhythmic events independently of QTc (odds ratio 1.25; 95% CI, 1.11-1.40; P = 0.001). Adding EMW to QTc for risk assessment led to a net reclassification improvement of 13.3% (P = 0.03). No EMW differences were found between the three major LQTS genotypes.

Conclusions: Patients with genotype-positive LQTS express EMW negativity, which is most pronounced in patients with documented arrhythmic events.

Keywords: Arrhythmia; Echocardiography; Ion channels; Long-QT syndrome; Sudden death.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Analysis of Variance
  • Anti-Arrhythmia Agents / therapeutic use
  • Arrhythmias, Cardiac / genetics
  • Case-Control Studies
  • Death, Sudden, Cardiac / prevention & control
  • ERG1 Potassium Channel
  • Electrocardiography
  • Ether-A-Go-Go Potassium Channels / genetics
  • Female
  • Genotype
  • Heterozygote
  • Humans
  • Ion Channels / genetics
  • Ion Channels / physiology
  • KCNQ1 Potassium Channel / genetics
  • Long QT Syndrome / drug therapy
  • Long QT Syndrome / genetics
  • Long QT Syndrome / physiopathology*
  • Male
  • Mutation / genetics
  • NAV1.5 Voltage-Gated Sodium Channel / genetics
  • Potassium Channels, Voltage-Gated / genetics
  • Risk Factors
  • Ultrasonography, Doppler

Substances

  • Adrenergic beta-Antagonists
  • Anti-Arrhythmia Agents
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • Ion Channels
  • KCNE1 protein, human
  • KCNE2 protein, human
  • KCNQ1 Potassium Channel
  • KCNQ1 protein, human
  • NAV1.5 Voltage-Gated Sodium Channel
  • Potassium Channels, Voltage-Gated
  • SCN5A protein, human